Skip to content
  • Home
  • About
    • Management Team
    • Board of Directors
  • Pipeline
    • ENAC PULMONARY
    • tPAD
    • Mucolytic Agents
    • Research
    • Clinical Trials
  • News and Events
  • Partnerships
  • Careers
  • Contact

Parion Sciences

Monthly Archives: June 2014

Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA)

June 19, 2014News & EventPaul Boucher

Continue reading Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA) →

Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories

June 12, 2014News & EventPaul Boucher

Continue reading Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories →

Parion Sciences Announces Senior Leadership and Organizational Changes

June 2, 2014News & EventPaul Boucher

Continue reading Parion Sciences Announces Senior Leadership and Organizational Changes →

Recent Posts

  • Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine
  • Parion Sciences Receives Positive Opinion from EMA Paediatric Committee on the Paediatric Investigation Plan for Idrevloride Inhalation Solution for Treatment of Primary Ciliary Dyskinesia
  • Parion Sciences P‐1037 Inhalation Solution receives Orphan Drug Designation from the EMA for the Treatment of Primary Ciliary Dyskinesia
  • FDA Grants Orphan Drug Designation, Fast Track Designation and Rare Pediatric Disease Designation to Parion Sciences P-1037 Inhalation Solution for the Treatment of Primary Ciliary Dyskinesia
  • Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors

Recent Comments

    Archives

    • September 2023
    • April 2023
    • November 2020
    • July 2020
    • January 2020
    • October 2019
    • May 2017
    • November 2016
    • October 2016
    • July 2016
    • May 2016
    • January 2016
    • October 2015
    • September 2015
    • June 2015
    • May 2015
    • February 2015
    • November 2014
    • October 2014
    • September 2014
    • June 2014
    • May 2014
    • April 2014
    • November 2013

    Categories

    • News & Event
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Home | About | Pipeline |
    Expanded Access |
    News & Events | Partnerships | Careers | Contact | FCOI Policy

    Copyright © 2025. All Rights Reserved.

    Main menu
    AcceptParion uses cookies on this website with your consent to analyze traffic and to improve your user experience. For more information, including about the cookies we use and how to control cookies, please see our Privacy Policy. By continuing to surf on our website, you consent to the use of cookies. You can always opt out (e.g. by deleting the cookies), however, you may not be able to use the full functionalities of the website if you do.
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT